Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02582489 · ClinicalTrials.gov registry record · NA
Autologous Bone Marrow Aspirate Concentrate in Patients Undergoing Meniscectomy
A NA study of Osteoarthritis Post-meniscectomy, sponsored by Rush University Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT02582489 is a NA study of Osteoarthritis Post-meniscectomy that is actively recruiting participants, run by Rush University Medical Center. The registered enrollment target is 100 participants. The trial reports 1 study location across 1 state.
The verdict
NCT02582489, a NA study of Osteoarthritis Post-meniscectomy, is actively recruiting participants, sponsored by Rush University Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The proposed research study aims to evaluate the effects of autologous bone marrow aspirate concentrate (BMAC) on the development and progression of osteoarthritis (OA) in patients undergoing meniscectomy. This prospective, randomized, double-blind clinical trial will compare patient-reported outcomes, specifically IKDC scores between patients who receive BMAC post-meniscectomy and those who receive a saline control injection. The study will also compare physical examination, MRI, radiographs, and synovial fluid analysis. Our hypothesis is that those who receive the autologous BMAC injection after the procedure will have better outcomes than those who do not.
Conditions Studied
Interventions
- BIOLOGICAL Bone Marrow Aspirate Concentrate
- PROCEDURE Standard Meniscectomy
Study Locations (1)
Illinois
- Rush University Medical Center - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2017-12-22 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02582489
The ClinicalTrials.gov registry entry for NCT02582489 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rush University Medical Center, which has 320 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Osteoarthritis Post-meniscectomy appearing as the primary indexed condition, and to 2 interventions - of which Bone Marrow Aspirate Concentrate is the first listed.
NCT02582489 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT02582489 about?
NCT02582489 is a clinical study titled "Autologous Bone Marrow Aspirate Concentrate in Patients Undergoing Meniscectomy". The proposed research study aims to evaluate the effects of autologous bone marrow aspirate concentrate (BMAC) on the development and progression of osteoarthritis (OA) in patients undergoing meniscectomy. This prospective, randomized, double-blind clinical trial will compare patient-reported outcom...
What is the current status of trial NCT02582489?
This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2017-12-22. Estimated completion is 2026-12-31.
What conditions does trial NCT02582489 study?
This clinical trial studies the following conditions: Osteoarthritis Post-meniscectomy.
What interventions are being tested in trial NCT02582489?
The interventions under investigation include: Bone Marrow Aspirate Concentrate (BIOLOGICAL), Standard Meniscectomy (PROCEDURE).
Who is sponsoring clinical trial NCT02582489?
This trial is sponsored by Rush University Medical Center, which has 320 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02582489 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.